Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kefford

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaE M Hersh, M Del Vecchio, M P Brown, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaE M Hersh, M Del Vecchio, M P Brown, et al.
Pageof 4